Clinically, an elevated Treg/CD8+ ratio has been consistently associated with poorer overall survival and reduced responses to ICIs (14, 15), underscoring the prognostic value of T-cell profiling in both early- and late-stage lung cancer (16). Here, CD8A is linked to lung carcinoma.